PANDEMIE DE LA COVID-19 ET PRISE EN CHARGE THERAPEUTIQUE DU PATIENT ATTEINT DE DIABETE DE TYPE 2 : QUEL IMPACT ?

Files in this item

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account